|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3000 USD | -.--% |
|
-.--% | - |
| 25-10-02 | Joint Disclosure Statement Approved for Irwin Naturals, Inc. | CI |
| 25-09-10 | Reorganization Plan Filed by Irwin Naturals, Inc. | CI |
| Market Cap | 485K 423K 390K 367K 685K 45.72M 691K 4.64M 1.8M 22.5M 1.82M 1.78M 78.16M | P/E 2021 |
105x | P/E 2022 | -0.94x |
|---|---|---|---|---|---|
| Enterprise Value | 21.01M 18.33M 16.9M 15.91M 29.7M 1.98B 29.95M 201M 78.02M 975M 78.87M 77.17M 3.39B | EV / Sales 2021 |
0.13x | EV / Sales 2022 | 0.32x |
| Free-Float |
1.04% | Yield 2021 * |
-
| Yield 2022 | - |
| 3 years | 0.05 |  | 1.5 |
| 5 years | 0.05 | | 4.75 |
| 10 years | 0.05 | | 4.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CEO | Chief Executive Officer | 60 | 1993-12-31 |
Mark Green
DFI | Director of Finance/CFO | - | 2024-03-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CHM | Chairman | 60 | 1993-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21-08-15 | Other | Chief Executive Officer | 0 | - | ||
| 21-08-15 | Marche | Chief Executive Officer | 1 | - | ||
| 21-08-15 | Marche | Chief Executive Officer | 18,240 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | -80.00% | 721K | |
| -1.21% | -3.33% | +38.84% | +145.38% | 992B | |
| -2.48% | -4.23% | +49.88% | +39.07% | 564B | |
| -2.14% | -3.76% | +16.72% | +56.15% | 391B | |
| -1.18% | +0.68% | +24.66% | +16.53% | 330B | |
| -2.36% | -2.30% | +23.37% | +11.59% | 280B | |
| -2.45% | -0.84% | +23.51% | +30.06% | 279B | |
| -1.91% | -1.06% | -42.60% | -49.25% | 196B | |
| -1.19% | -0.04% | +16.39% | +47.00% | 184B | |
| -1.35% | +1.88% | +14.59% | +56.94% | 156B | |
| Average | -0.76% | +5.01% | +16.54% | +27.35% | 337.12B | |
| Weighted average by Cap. | -0.51% | -0.49% | +27.10% | +63.21% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 100M 87.54M 80.7M 75.99M 142M 9.46B 143M 960M 373M 4.66B 377M 369M 16.18B | 89.47M 78.05M 71.95M 67.76M 126M 8.44B 128M 856M 332M 4.15B 336M 329M 14.43B |
| Net income | 8.62M 7.52M 6.93M 6.52M 12.18M 813M 12.28M 82.38M 31.99M 400M 32.33M 31.64M 1.39B | -3.99M -3.48M -3.21M -3.02M -5.64M -377M -5.69M -38.17M -14.82M -185M -14.98M -14.66M -644M |
| Net Debt | 9.35M 8.16M 7.52M 7.08M 13.22M 882M 13.33M 89.44M 34.73M 434M 35.1M 34.35M 1.51B | 20.53M 17.91M 16.51M 15.55M 29.01M 1.94B 29.26M 196M 76.22M 953M 77.05M 75.39M 3.31B |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- IWIN Stock
Select your edition
All financial news and data tailored to specific country editions
